Dr. Ann A. Jakubowski, MD

Dr. Jakubowski practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Jakubowski's NPI, 1467555342, was assigned on September 6, 2006. Dr. Jakubowski graduated from Uconn School Of Medicine in 1981. Dr. Jakubowski holds New York license 151794.

Dr. Jakubowski's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Jakubowski's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Jakubowski to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jakubowski practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Jakubowski's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Jakubowski is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Jakubowski's licenses on file in 4 states: New York, Florida, New Jersey and Connecticut.

Dmand AI lists chronic anemia, chronic leukemia and multiple myeloma among the conditions Dr. Jakubowski treats.

CMS data shows 404 Medicare services from Dr. Jakubowski across 3 procedure codes in 2024, for 78 Medicare patients. Medicare paid $42,675 for them.

CMS counts 78 Medicare patients who saw Dr. Jakubowski in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jakubowski's median patient age at 67, with 46% women.

In 2024, Dr. Jakubowski wrote 386 Medicare Part D claims for 51 patients. 81% of them were for generic drugs. CMS names the drug for 262 of them, across 10 drugs with 11 or more claims each, at $216,842 in total drug cost. In 2023, CMS named 149 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Jakubowski for performance year 2024, reported as part of a group. Dr. Jakubowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jakubowski as offering telehealth.

Dmand AI links 226 papers to Dr. Jakubowski, published from 2002 to 2024. 2017 was the busiest year, with 20. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Transplantation Conditioning. Dr. Jakubowski has published most often in Biol Blood Marrow Transplant. Dr. Jakubowski's most frequent co-authors are Sergio A. Giralt, MD, Esperanza Papadopoulos, MD and Miguel A. Perales, MD.

Dmand AI links Dr. Jakubowski to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Blast Crisis, Hemoglobinuria, Paroxysmal and Renal Insufficiency. Memorial Sloan Kettering Cancer Center sponsors the most, 3.

CMS Open Payments shows 28 general payments to Dr. Jakubowski from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 98% of the total. National Marrow Donor Program paid the most, $122,481.

Dmand AI lists 1 award for Dr. Jakubowski, most recently Top Doctors: New York Metro Area in 2014.

Dr. Jakubowski graduated from Uconn School Of Medicine in 1981.

Dr. Jakubowski is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.